India and Oman Pharmaceutical Industry Market Growth Accelerated by Increasing Generic Drugs Demand
Pharmaceutical Industry Market |
India and Oman pharmaceutical industry market has witnessed robust growth riding on affordable medications demand. Generic drugs are affordable versions of brand-name drugs that have the same intended use, dosage, effects, risks, safety, strength, and quality. Generic drugs account for around 75%-80% of the total pharma sales in India as they provide cost-effective treatment options to a huge patient pool. The growing incidence of chronic diseases and rising healthcare expenditure in India and Oman have accelerated generic drugs demand.
India and
Oman Pharmaceutical Industry Market is estimated to be valued at US$ 45 Billion
in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024
to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing generic drugs demand has been a key growth driver for India and
Oman pharmaceutical industry market. Generic drugs have significantly low
prices as compared to their branded counterparts which make treatment
affordable for a large section of patients in India and Oman. As per government
estimates, generic drugs are 60%-70% cheaper than branded medicines. This has
boosted their demand over the past few years. The price differential is
expected to further widen in the coming years supported by pro-generic drugs
policies of governments in both nations. This will continue promoting generic
drugs uptake, thereby augmenting growth in the overall pharmaceutical industry
market of India and Oman during the forecast period.
Comments
Post a Comment